Source: Annual Congress 2012 - ERS/NEJM Lunchtime session "Advances in asthma and COPD"
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L.M. Fabbri (Modena, Italy). Review on the clinical recognition and treatment of COPD exacerbations. Annual Congress 2012 - ERS/NEJM Lunchtime session "Advances in asthma and COPD"

Member's Comments

No comment yet.

Related content which might interest you: Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 National clinical audit for hospitalised exacerbations of COPD Source: ERJ Open Res, 6 (3) 00208-2020; 10.1183/23120541.00208-2020 Year: 2020 High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 The role of IFN-γ in severe COPD patients with anamnestic viral-induced exacerbations before and after roflumilast treatment Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Clinical and functional effectiveness of roflumilast in severe COPD patients Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Physician consultation and outcomes of treatment in exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Physical therapy effects on psychological functions in patients with acute COPD exacerbation Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma Year: 2013 Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Short-acting bronchodilators for in-hospital management of acute exacerbation of COPD: Systematic Review Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Short term outcomes of pulmonary rehabilitation: A comparison between patients immediately after hospitalization for AECOPD and stable COPD patients Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1 Year: 2014 Compare clinical effectiveness of various types of bronchodilators in COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Clinical pathway for acute COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 Safety and efficacy of sputum induction in COPD patients Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013